Royal Bank of Canada’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-70,094	Closed	-$998K	–	7171
2023 Q4	$998K	Buy	70,094 +63,594	+978%	+$905K	﹤0.01%	3194
2023 Q3	$75K	Buy	+6,500	New	+$75K	﹤0.01%	5081
2022 Q4	–	Sell	-42,453	Closed	-$46K	–	7335
2022 Q3	$46K	Buy	+42,453	New	+$46K	﹤0.01%	5299